Comments
Drug firm Cadila Healthcare today said the US health regulator has issued no observations after completion of inspection of its Moraiya plant in Gujarat.
The USFDA has inspected the company’s Moraiya facility from August 31 to September 7, Cadila Healthcare said in a statement. “At the end of the inspection, no observation (483) is issued”, it added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.